These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 33423017)
1. Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study. Milano C; Turco F; Pizzanelli C; Bonanni E; Siciliano G; Fornai F; Giorgi FS Epilepsy Behav; 2021 Feb; 115():107706. PubMed ID: 33423017 [TBL] [Abstract][Full Text] [Related]
2. Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020. Kılıç B; Serdaroğlu E; Polat BG; İnce T; Esenülkü G; Topçu Y; Serdaroğlu A; Haspolat Ş; Tekgül H; Okuyaz Ç; Cansu A; Aydın K Seizure; 2022 Jul; 99():48-53. PubMed ID: 35594744 [TBL] [Abstract][Full Text] [Related]
3. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy. Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate. Chowdhury A; Brodie MJ Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy. Ascoli M; Mastroianni G; Gasparini S; Striano P; Cianci V; Neri S; Bova V; Mammì A; Gambardella A; Labate A; Aguglia U; Ferlazzo E Expert Rev Neurother; 2021 Nov; 21(11):1265-1273. PubMed ID: 33993822 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623 [TBL] [Abstract][Full Text] [Related]
12. Treatment of juvenile myoclonic epilepsy. Auvin S CNS Neurosci Ther; 2008; 14(3):227-33. PubMed ID: 18684236 [TBL] [Abstract][Full Text] [Related]
13. Effects of valproate, lamotrigine, and levetiracetam monotherapy on bone health in newly diagnosed adult patients with epilepsy. Guo Y; Lin Z; Huang Y; Yu L Epilepsy Behav; 2020 Dec; 113():107489. PubMed ID: 33220583 [TBL] [Abstract][Full Text] [Related]
14. Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy. Johannessen Landmark C; Fløgstad I; Syvertsen M; Baftiu A; Enger U; Koht J; Johannessen SI Epilepsy Behav; 2019 Sep; 98(Pt A):110-116. PubMed ID: 31330379 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of anti-epileptic drugs-an internet study. Wieshmann UC; Baker G Acta Neurol Scand; 2017 May; 135(5):533-539. PubMed ID: 27757951 [TBL] [Abstract][Full Text] [Related]
16. The use of lamotrigine in juvenile myoclonic epilepsy. Buchanan N Seizure; 1996 Jun; 5(2):149-51. PubMed ID: 8795132 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy. Gürer R; Aydın Ş; Özkara Ç Seizure; 2019 Aug; 70():43-48. PubMed ID: 31252363 [TBL] [Abstract][Full Text] [Related]
18. [Juvenile myoclonic epilepsy with recurrent myoclonic status: efficacy of valproate]. Crespel A; Velizarova R; Genton P; Gélisse P Therapie; 2009; 64(5):321-3. PubMed ID: 19863907 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy. Johannessen Landmark C; Fløgstad I; Baftiu A; Syvertsen M; Enger U; Koht J; Johannessen SI Epilepsy Res; 2019 Sep; 155():106148. PubMed ID: 31195184 [TBL] [Abstract][Full Text] [Related]